A Phase 1 Study of Nivolumab in Combination with Interferon-Gamma for Patients with Advanced Solid Tumors
Nature Communications(2023)
Key words
Cancer immunotherapy,Cancer therapeutic resistance,Science,Humanities and Social Sciences,multidisciplinary
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined